Breaking News Instant updates and real-time market news.

2017-05-15 14:08:25 EXAS Exact Sciences $33.77 -0.65 (-1.89%) 14:08 05/15/17 05/15 14:08 05/15/17 14:08	Exact Sciences should be bought on weakness, says Canaccord Canaccord analyst Mark Massaro notes that Exact Sciences' shares are off following a short report published by Citron Research, and followed by a 1-on-1 appearance between the lead author of the short report and Kevin Conroy, Chairman and CEO of Exact Sciences. However, the analyst believes the author's short report to be flawed in several key areas, namely when it stated that "Colonoscopy is the gold standard" and is perfectly sensitive, "Exact Sciences will never be profitable," Medicare pricing will decline, Exact Sciences "terminal value might be $0," "Cologuard is not effective," and that there is no operating leverage. Massaro reiterates a Buy rating and $38 price target on the shares and says he is a buyer on weakness.	16 May 30 May 06 Jun
EXAS Exact Sciences $33.77 -0.65 (-1.89%) 05/05/17 COWN 05/05/17 NO CHANGE Target $40 COWN Outperform Exact Sciences Cologuard survey boosts confidence in demand, says Cowen Cowen analyst Doug Schenkel surveyed physicians regarding the usage of Exact Sciences' Cologuard and found strong perception and projected uptake, which boosted his confidence in the outlook for its demand over the next three years. Schenkel believes revenue could easily approach or exceed $700M in 2019, which is $200M above the firm's current forecast, and the annual revenue opportunity could exceed $4B. Schenkel reiterated his Outperform rating and $40 price target on Exact Sciences shares. 04/28/17 LEER 04/28/17 NO CHANGE Target $38 LEER Outperform Exact Sciences price target raised to $38 from $30 at Leerink Leerink analyst Puneet Souda raised his price target for Exact Sciences to $38 from $30 as the company reported revenues above estimates and further upped its guidance for the year on the back of solid momentum. The analyst believes the momentum will continue with expectations that Exact Sciences will meet and likely exceed the upper end of the guided range for 2017. He reiterates an Outperform rating on the shares. 04/28/17 BARD 04/28/17 NO CHANGE Target $35 BARD Outperform Exact Sciences price target raised to $35 from $26 at Baird Baird analyst Catherine Ramsey Schulte raised her price target on Exact Sciences to $35 from $36 following significantly better than expected Q1 results. She noted the company's increased guidance, adding that with fundamentals seemingly strong, guidance could be conservative. Schulte reiterated her Outperform rating on Exact Sciences shares. 04/28/17 ROTH 04/28/17 NO CHANGE Target $33 ROTH Buy Exact Sciences price target raised to $33 from $26 at Roth Capital Roth Capital analyst Chris Lewis raised his price target for Exact Sciences to $33 from $26 after the company announced a "strong 1Q" beat across the board with volumes, ASPs, revenues, and gross margins all exceeding expectations. With USPSTF inclusion driving expanding reimbursement coverage, quality metrics inclusion driving physician adoption, and continued effective DTC initiatives, the analyst believes Exact Sciences is well-positioned to sustain "strong commercial momentum." He reiterates a Buy rating on the shares.

2017-05-15 14:08:25

EXAS

Exact Sciences

$33.77: -0.65 (-1.89%)

14:08

05/15/17

05/15

14:08

05/15/17

14:08

Exact Sciences should be bought on weakness, says Canaccord

Canaccord analyst Mark Massaro notes that Exact Sciences' shares are off following a short report published by Citron Research, and followed by a 1-on-1 appearance between the lead author of the short report and Kevin Conroy, Chairman and CEO of Exact Sciences. However, the analyst believes the author's short report to be flawed in several key areas, namely when it stated that "Colonoscopy is the gold standard" and is perfectly sensitive, "Exact Sciences will never be profitable," Medicare pricing will decline, Exact Sciences "terminal value might be $0," "Cologuard is not effective," and that there is no operating leverage. Massaro reiterates a Buy rating and $38 price target on the shares and says he is a buyer on weakness.

16
May
30
May
06
Jun

EXAS Exact Sciences

$33.77: -0.65 (-1.89%)

05/05/17: COWN

04/28/17: LEER

04/28/17: BARD

04/28/17: ROTH

TODAY'S FREE FLY STORIES

ALNY Alnylam $64.09 -1.71 (-2.60%) 07:34 05/31/17 05/31 07:34 05/31/17 07:34 Hot Stocks	FDA grants Breakthrough Therapy Designation for Alnylam's Givosiran » Alnylam Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Jun
DAKT Daktronics $9.28 0.14 (1.53%) 07:33 05/31/17 05/31 07:33 05/31/17 07:33 Earnings	Daktronics reports Q4 EPS 2c, consensus 6c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
EC Ecopetrol $9.36 -0.23 (-2.40%) 07:33 05/31/17 05/31 07:33 05/31/17 07:33 Downgrade	Ecopetrol rating change » Ecopetrol downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
DNKN Dunkin' Brands $58.32 0.15 (0.26%) 07:32 05/31/17 05/31 07:32 05/31/17 07:32 Hot Stocks	Dunkin' Brands names Kate Jaspon as CFO, effective June 5 » Dunkin' Brands Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Jun
EXAS Exact Sciences $32.65 -0.67 (-2.01%) , UNH UnitedHealth $176.59 -0.91 (-0.51%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Recommendations	Exact Sciences, UnitedHealth analyst commentary » Exact Sciences remains a… EXAS Exact Sciences $32.65 -0.67 (-2.01%) UNH UnitedHealth $176.59 -0.91 (-0.51%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 31 May 06 Jun

QCOM Qualcomm $57.34 -0.18 (-0.31%) , NXPI NXP Semiconductors $108.14 0.14 (0.13%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Hot Stocks	Qualcomm extends cash tender offer for NXP Semiconductors outstanding shares » Qualcomm (QCOM) announced… QCOM Qualcomm $57.34 -0.18 (-0.31%) NXPI NXP Semiconductors $108.14 0.14 (0.13%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun 09 Jun
FRO Frontline $5.41 -0.22 (-3.91%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Upgrade	Frontline rating change » Frontline upgraded to Buy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EGHT 8x8, Inc. $13.60 0.1 (0.74%) 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Conference/Events	8x8, Inc. management to meet with Needham » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 01 Jun 06 Jun 06 Jun 08 Jun 13 Jun
GNRT Gener8 Maritime $4.91 0.06 (1.24%) , FRO Frontline $5.41 -0.22 (-3.91%) … 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Recommendations	Gener8 Maritime, Frontline, DHT Holdings analyst commentary » Gener8 Maritime advance… GNRT Gener8 Maritime $4.91 0.06 (1.24%) FRO Frontline $5.41 -0.22 (-3.91%) DHT DHT Holdings $4.20 -0.07 (-1.64%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WLL Whiting Petroleum $7.28 -0.69 (-8.66%) , ORCL Oracle $45.42 0.16 (0.35%) 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Options	Unusual put flow in option market yesterday » Notable put activity was… WLL Whiting Petroleum $7.28 -0.69 (-8.66%) ORCL Oracle $45.42 0.16 (0.35%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

KORS Michael Kors $36.27 -0.49 (-1.33%) 07:25 05/31/17 05/31 07:25 05/31/17 07:25 Technical Analysis	Technical View: Michael Kors drops to new 52-week low after earnings » In the pre-market the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
CBS CBS $61.52 -0.05 (-0.08%) , CBS.A $63.50 -0.15 (-0.24%) … 07:24 05/31/17 05/31 07:24 05/31/17 07:24 Periodicals	Scott Pelley to depart anchor role on 'CBS Evening News,' NY Times says » CBS (CBS, CBS.A) news… CBS CBS $61.52 -0.05 (-0.08%) CBS.A $63.50 -0.15 (-0.24%) CMCSA Comcast $41.10 0.19 (0.46%) CMCSK Comcast DIS Disney $108.34 -0.07 (-0.06%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun 08 Jun 15 Jun
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:23 05/31/17 05/31 07:23 05/31/17 07:23 Hot Stocks	Breaking Hot Stocks news story on Michael Kors » Michael Kors drops 7% in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
UAA Under Armour $19.56 -0.13 (-0.66%) 07:23 05/31/17 05/31 07:23 05/31/17 07:23 Recommendations	Under Armour analyst commentary » Under Armour has reached… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
07:22 05/31/17 05/31 07:22 05/31/17 07:22 General news	Futures higher ahead of final trading for May » Stock futures are above… Stock futures are above fair value as the final trading session of May is set to begin. World markets closed trading with gains for the month as investors stateside will be looking ahead to Friday's nonfarm payrolls report. Today though they will see the Chicago purchasing manager's report and pending home sales data. The weekly oil numbers, which are normally released on Wednesday, will be delayed until tomorrow due to the Memorial Day holiday. In early trading, Dow futures are 18 points above fair value, Nasdaq futures are 12 points above fair value and S&P futures are 2 points above fair value.

KORS Michael Kors $36.27 -0.49 (-1.33%) 07:22 05/31/17 05/31 07:22 05/31/17 07:22 Hot Stocks	Michael Kors says to close 100-125 full-price retail stores over next two years » Michael Kors announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
MYL Mylan $39.36 -0.36 (-0.91%) 07:19 05/31/17 05/31 07:19 05/31/17 07:19 Recommendations	Mylan analyst commentary » Pension fund campaign a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Sep 09 Oct
VIAB Viacom $35.05 -0.08 (-0.23%) , VIA Viacom $38.90 0.5 (1.30%) 07:17 05/31/17 05/31 07:17 05/31/17 07:17 Recommendations	Viacom, Viacom analyst commentary » Viacom price target… VIAB Viacom $35.05 -0.08 (-0.23%) VIA Viacom $38.90 0.5 (1.30%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
XXII 22nd Century $1.37 -0.02 (-1.44%) 07:17 05/31/17 05/31 07:17 05/31/17 07:17 Hot Stocks	22nd Century reports 'dramatic surge' in VLN tobacco clinical trials, science » 22nd Century Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ABT Abbott $45.00 0.29 (0.65%) 07:16 05/31/17 05/31 07:16 05/31/17 07:16 Recommendations	Abbott analyst commentary » Abbott making progress, … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

GRMN Garmin $52.11 -0.29 (-0.55%) 07:15 05/31/17 05/31 07:15 05/31/17 07:15 Hot Stocks	Garmin launches Approach S60 golf watch » Garmin International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SLCA U.S. Silica $36.45 -0.76 (-2.04%) 07:15 05/31/17 05/31 07:15 05/31/17 07:15 Technical Analysis	Technical View: U.S. Silica trades higher in pre-market » In the pre-market the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Jun
GPRK GeoPark $8.71 -0.18 (-2.02%) 07:12 05/31/17 05/31 07:12 05/31/17 07:12 Hot Stocks	GeoPark names Coulter Enterprises Chairman and CEO Coulter to board » GeoPark Limited announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PRQR ProQR Therapeutics $4.70 -0.3 (-6.00%) 07:12 05/31/17 05/31 07:12 05/31/17 07:12 Hot Stocks	ProQR Therapeutics' QR-110 granted Fast Track designation by FDA » ProQR Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MOH Molina Healthcare $66.30 -0.57 (-0.85%) 07:11 05/31/17 05/31 07:11 05/31/17 07:11 Downgrade	Molina Healthcare rating change » Molina Healthcare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 08:00

Fed Bank President Kaplan Takes Part in a Discussion Government Event

New York, NY
JILL
Today at 08:00

J.Jill - JILL Conference Calls
KORS
Today at 08:00

Michael Kors - KORS Conference Calls
BWFG
Today at 08:00

Bankwell Financial Firm Sponsored Meetings

Woodway Country Club--540 Hoyt Street, Darien, CT
CUBE
Today at 08:00

CubeSmart Firm Sponsored Meetings

Co Offices--5 Old Lancaster Road, Malvern, PA
SCOR
Today at 08:30

comScore - SCOR Conference Calls
PRGO
Today at 08:30

Perrigo - PRGO Conference Calls
NVS
Today at 08:30

Novartis Firm Sponsored Meetings
ONCE
Today at 08:30

Spark Therapeutics Firm Sponsored Meetings

Offices of Ballard Spahr LLP--1735 Market Street, Philadelphia, PA
Today at 08:55

Redbook Store Sales Y/Y: Week 5/27 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ARI X ARI Apollo Commercial Spot Secondary Managers: Citi, JPMorgan, BofA/Merrill & Morgan Stanley $18.25-18.60 1.2M Shares JRVR X JRVR James River Group Spot Secondary Managers: Morgan Stanley $40.00-41.00 4.25M Shares STAY X STAY Extended Stay America Spot Secondary Managers: Morgan Stanley & Citi $17.50-17.60 2.5B Shares
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Exact Sciences should be bought on weakness, says Canaccord

TODAY'S FREE FLY STORIES

Get Full Fly Access